Potential for clinical ex vivo expansion of cord blood haemopoietic stem cells using non-haemopoietic factor supplements

Current Stem Cell Research and Therapy

Volumn 2, Issue 3, 2007, Pages 229-237

  Hutton, Jonathon F ^a,b   D'Andrea, Richard J ^b   Lewis, Ian D ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cord blood; Ex vivo expansion; Growth factors; Haemopoietic stem cells; Stem cell transplantation

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; CCAAT ENHANCER BINDING PROTEIN ALPHA; FIBROBLAST GROWTH FACTOR; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HOX PROTEIN; HOXB4 PROTEIN; INTERLEUKIN 3; INTERLEUKIN 6; NOTCH RECEPTOR; RETINOIC ACID; SONIC HEDGEHOG PROTEIN; STEM CELL FACTOR; THROMBOPOIETIN; UNCLASSIFIED DRUG; WNT PROTEIN;

CELL CULTURE; CELL INTERACTION; CELL RENEWAL; COCULTURE; CORD BLOOD STEM CELL TRANSPLANTATION; EX VIVO STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VIVO STUDY; MESODERM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL;

ANIMALS; ANTIGENS, CD34; CELL CULTURE TECHNIQUES; COCULTURE TECHNIQUES; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRETINOIN; WNT PROTEINS;

EID: 34848864505     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488807781696221     Document Type: Review

References (154)

1. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-1178.
2. Rubinstein P. Why cord blood? Human immunology 2006; 67: 398-404.
3. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
4. Brunstein CG, Wagner JE. Umbilical cord blood transplantation and banking. Ann Rev Med 2006; 57: 403-417.
5. Rocha V, Garnier F, Ionescu I, Gluckman E. Hematopoietic stem-cell transplantation using umbilical-cord blood cells. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 2005; 57: 314-323.
6. Broxmeyer HE, Gluckman E, Auerbach A, et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/ progenitor cells. Int J Cell Cloning 1990; 8 (Suppl 1): 76-89; discussion 89-91.
7. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618.
8. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-2285.
9. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-2275.
10. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors [see comments]. N Engl J Med 1998; 339: 1565-1577.
11. Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 1986; 45: 917-927.
12. Weissman I, Spangrude G, Heimfeld S, Smith L, Uchida N. Stem cells. Nature 1991; 353: 26.
13. Abramson S, Miller RG, Phillips RA. The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J Exp Med 1977; 145: 1567-1579.
14. McKenzie JL, Gan OI, Doedens M, Wang JC, Dick JE. Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment. Nat Immunol 2006; 7: 1225-1233.
15. Mohamed AA, Ibrahim AM, El-Masry MW, et al. Ex vivo expansion of stem cells: defining optimum conditions using various cytokines. Lab Hematol 2006; 12: 86-93.
16. Haylock DN, Horsfall MJ, Dowse TL, et al. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood 1997; 90: 2260-2272.
17. Bhatia M, Bonnet D, Kapp U, Wang JC, Murdoch B, Dick JE. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997; 186: 619-624.
18. Madlambayan GJ, Rogers I, Casper RF, Zandstra PW. Controlling culture dynamics for the expansion of hematopoietic stem cells. J Hematother Stem Cell Res 2001; 10: 481-492.
19. Verfaillie CM. Can human hematopoietic stem cells be cultured ex vivo? Stem Cells 1994; 12: 466-476.
20. Wineman J, Moore K, Lemischka I, Muller-Sieburg C. Functional heterogeneity of the hematopoietic microenvironment: rare stromal elements maintain long-term repopulating stem cells. Blood 1996; 87: 4082-4090.
21. Breems DA, Blokland EA, Siebel KE, Mayen AE, Engels LJ, Ploemacher RE. Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells. Blood 1998; 91: 111-117.
22. McNiece I, Briddell R. Ex vivo expansion of hematopoietic progenitor cells and mature cells. Exp Hematol 2001; 29: 3-11.
23. Brugger W, Mocklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L, Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 1993; 81: 2579-2584.
24. Bhardwaj G, Murdoch B, Wu D, et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001; 2: 172-180.
25. Bhatia M, Bonnet D, Wu D, et al. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med 1999; 189: 1139-1148.
26. Reya T, Duncan AW, Ailles L, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003; 423: 409-414.
27. Karanu FN, Murdoch B, Gallacher L, et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoitic stem cells. J Exp Med 2000; 192: 1365-1372.
28. Karanu FN, Murdoch B, Miyabayashi T, et al. Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood 2001; 97: 1960-1967.
29. Choong ML, Tan AC, Luo B, Lodish HF. A novel role for proliferin-2 in the ex vivo expansion of hematopoietic stem cells. FEBS Lett 2003; 550: 155-162.
30. de Haan G, Weersing E, Dontje B, et al. In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. Dev Cell 2003; 4: 241-251.
31. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 2003; 9: 1428-1432.
32. Lai EC. Notch signaling: control of cell communication and cell fate. Development (Cambridge, England) 2004; 131: 965-973.
33. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control: and signal integration in development. Science 1999; 284: 770-716.
34. Yoon K, Gaiano N. Notch signaling in the mammalian central nervous system: insights from mouse mutants. Nat Neurosci 2005; 8: 709-715.
35. Mumm JS, Kopan R. Notch signaling: from the outside in. Develop Biol 2000; 128: 151-165.
36. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev 2006; 7: 678-689.
37. Fortini ME. Notch and presenilin: a proteolytic mechanism emerges. Curr Opin Cell Biol 2001; 13: 627-634.
38. Kojika S, Griffin JD. Notch receptors and hematopoiesis. Exp Hematol 2001; 29: 1041-1052.
39. Ohishi K, Vamum-Finney B, Bernstein ID. The notch pathway: modulation of cell fate decisions in hematopoiesis. Int J Hematol 2002; 75: 449-459.
40. Delassus S, Cumano A. Circulation of hematopoietic progenitors in the mouse embryo. Immunity 1996; 4: 97-106.
41. Williams R, Lendahl U, Lardelli M. Complementary and combinatorial patterns of Notch gene family expression during early mouse development. Mech Develop 1995; 53: 357-368.
42. Walker L, Carlson A, Tan-Pertel HT, Weinmaster G, Gasson J. The notch receptor and its ligands are selectively expressed during hematopoietic development in the mouse. Stem cells (Dayton, Ohio) 2001; 19: 543-552.
43. Conlon RA, Reaume AG, Rossant J. Notch1 is required for the coordinate segmentation of somites. Development (Cambridge, England) 1995; 121: 1533-1545.
44. Gridley T. Notch signaling during vascular development. Proc Natl Acad Sci USA 2001; 98: 5377-5378.
45. Jiang R, Lan Y, Chapman HD, et al. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. Genes Develop 1998; 12: 1046-1057.
46. Krebs LT, Xue Y, Norton CR, et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Develop 2000; 14: 1343-1352.
47. Hadland BK, Huppert SS, Kanungo J, et al. A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development. Blood 2004; 104: 3097-3105.
48. Kumano K, Chiba S, Kunisato A, et al. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 2003; 18: 699-711.
49. Milner LA, Kopan R, Martin DI, Bernstein ID. A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors,. Blood 1994; 83: 2057-2062.
50. Bigas A, Martin DI, Milner LA. Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Mol Cell Biol 1998; 18: 2324-2333.
51. Kumano K, Chiba S, Shimizu K, et al. Notch1 inhibits differentiation of hematopoietic cells by sustaining GATA-2 expression. Blood 2001; 98: 3283-3289.
52. Milner LA, Bigas A, Kopan R, Brashem-Stein C, Bernstein ID, Martin DI. Inhibition of granulocytic differentiation by mNotch1. Proc Natl Acad Sci USA 1996; 93: 13014-13019.
53. Varnum-Finney B, Xu L, Brashem-Stein C, et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med 2000; 6: 1278-1281.
54. Kunisato A, Chiba S, Nakagami-Yamaguchi E, et al. HES-1 preserves purified hematopoietic stem cells ex vivo and accumulates side population cells in vivo. Blood 2003; 101: 1777-1783.
55. Ohishi K, Varnum-Finney B, Bernstein ID. Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells. J Clin Investig 2002; 110: 1165-1174.
56. Suzuki T, Chiba S. Notch signaling in hematopoietic stem cells. Intern J Hematol 2005; 82: 285-294.
57. Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269-271.
58. Zhu YM, Zhao WL, Fu JF, et al. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Clin Cancer Res 2006; 12: 3043-3049.
59. Miller JR. The Wnts. Genome Biol 2002; 3: REVIEWS3001.
60. Mikels AJ, Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene 2006; 25: 7461-7468.
61. van Noort M, Clevers H. TCF transcription factors, mediators of Wnt-signaling in development and cancer. Develop Biol 2002; 244: 1-8.
62. Staal FJ, Clevers HC. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat Rev 2005; 5: 21-30.
63. Tamai K, Semenov M, Kato Y, et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 2000; 407: 530-535.
64. Hsieh JC. Specificity of WNT-receptor interactions. Front Biosci 2004; 9: 1333-1338.
65. Huelsken J, Birchmeier, W. New aspects of Wnt signaling, pathways in higher vertebrates. Curr Opin Genet Dev 2001; 11: 547-553.
66. Kimelman D, Christian JL, Moon RT. Synergistic principles of development: overlapping patterning systems in Xenopus mesoderm induction. Development 1992, 116: 1-9.
67. Gadue P, Huber TL, Paddison PJ, Keller GM, Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc Natl Acad Sci USA 2006; 103: 16806-16811.
68. Slack JM. Inducing factors in Xenopus early embryos. Curr Biol 1994; 4: 116-126.
69. Austin TW, Solar GP, Ziegler FC, Liem L, Matthews W. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 1997; 89: 3624-3635.
70. Van Den Berg DJ, Sharma AK, Bruno E, Hoffman R. Role of members of the Wnt gene family in human hematopoiesis. Blood 1998; 92: 3189-3202.
71. Cobas M, Wilson A, Ernst B, et al. Beta-catenin is dispensable for hematopoiesis and lymphopoiesis. J Exp Med 2004; 199: 221-229.
72. Duncan AW, Rattis FM, DiMascio LN, et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005; 6: 314-322.
73. Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000; 7: 165-197.
74. Bottcher RT, Niehrs C. Fibroblast growth factor signaling during early vertebrate development. Endocr Rev 2005; 26: 63-77.
75. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997; 138: 4456-4462.
76. Walsh S, Jefferiss C, Stewart K, Jordan GR, Screen J, Beresford JN. Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone 2000; 27: 185-195.
77. Kashiwakura I, Takahashi TA. Fibroblast growth factor and ex vivo expansion of hematopoietic progenitor cells. Leuk Lymphoma 2005; 46: 329-333.
78. Chen QS, Wang ZY, Han ZC. Enhanced growth of megakaryocyte colonies in culture in the presence of heparin and fibroblast growth factor. Int J Hematol 1999; 70: 155-162.
79. da Silva CL, Goncalves R, Lemos F, et al. Modelling of ex vivo expansion/maintenance of hematopoietic stem cells. Bioprocess Biosyst Eng 2003; 25: 365-369.
80. Yeoh JS, van Os R, Weersing E, et al. Fibroblast growth factor-1 and -2 preserve long-term repopulating ability of hematopoietic stem cells in serum-free cultures. Stem cells (Dayton, Ohio) 2006; 24: 1564-1572.
81. Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev 1996; 6: 432-438.
82. Kishigami S, Mishina Y. BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev 2005; 16: 265-278.
83. Mishina Y. Function of bone morphogenetic protein signaling during mouse development. Front Biosci 2003; 8: d855-869.
84. Yamashita H, Ten Dijke P, Heldin CH, Miyazono K. Bone morphogenetic protein receptors. Bone 1996; 19: 569-574.
85. Suzuki Y, Yandell MD, Roy PJ, et al. A BMP homolog acts as a dose-depandent regulator of body size and male tail patterning in Caenorhabditis elegans. Development 1999; 126: 241-250.
86. Shimell MJ, Ferguson EL, Childs SR, O'Connor MB. The Drosophila dorsal-ventral patterning gene tolloid is related to human bone morphogenetic protein 1. Cell 1991; 67: 469-481.
87. Newfeld SJ, Wisotzkey RG, Kumar S. Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-beta family ligands, receptors and Smad signal transducers. Genetics 1999; 152: 783-795.
88. Zhang J, Li L. BMP signaling and stem cell regulation. Dev Biol 2005; 284: 1-11.
89. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Develop 1992; 32: 160-167.
90. Dale L, Jones CM. BMP signalling in early Xenopus development. Bioessays 1999; 21: 751-760.
91. Dosch R, Gawantka V, Delius H, Blumenstock C, Niehrs C. Bmp-4 acts as a morphogen in dorsoventral mesoderm patterning in Xenopus. Development 1997; 124: 2325-2334.
92. Xu RH, Kim J, Taira M, et al. Differential regulation of neurogeneis by the two Xenopus GATA-1 genes. Mol Cell Biol 1997; 17: 436-443.
93. Maeno M, Mead PE, Kelley C, et al. The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic mesoderm in Xenopus laevis. Blood 1996; 88: 1965-1972.
94. Mead PE, Kelley CM, Hahn PS, Piedad O, Zon LI. SCL specifies hematopoietic mesoderm in Xenopus embryos. Development 1998; 125: 2611-2620.
95. Mead PE, Deconinck AE, Huber TL, Orkin SH, Zon LI. Primitive erythropoiesis in the Xenopus embryo: the synergistic role of LMO-2, SCL and GATA-binding proteins. Development 2001; 128: 2301-2308.
96. Hutton JF, Rozenkov V, Khor FS, D'Andrea RJ, Lewis ID. Bone morphogenetic protein 4 contributes to the maintenance of primitive cord blood hematopoietic progenitors in an ex vivo stroma-noncontact co-culture system. Stem Cells Develop 2006; 15: 805-813.
97. Hooper JE, Scott MP. Communicating with Hedgehogs. Nat Rev 2005; 6: 306-317.
98. Niswander L, Jeffrey S, Martin GR, Tickle C. A positive feedback loop coordinates growth and patterning in the vertebrate limb. Nature 1994; 371: 609-612.
99. Farrington SM, Belaoussoff M, Baron MH. Winged-helix, Hedgehog and Bmp genes are differentially expressed in distinct cell layers of the routine yolk sac. Mech Develop 1997; 62: 197-211.
100. Chiang C, Litingtung Y, Lee E, et al. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 1996; 383: 407-413.
101. Mandal L, Martinez-Agosto JA, Evans CJ, Hartenstein V, Banerjee U. A Hedgehog- and Antennapedia-dependent niche maintains Drosophila haematopoietic precursors. Nature 2007; 446: 320-324.
102. Kobune M, Ito Y, Kawano Y, et al. Indian hedgehog gene transfer augments hematopoietic support of human stromal cells including NOD/ SCID-beta2m-/- repopulating cells. Blood 2004; 104: 1002-1009.
103. Ross SA, McCaffery PJ, Drager UC, De Luca LM. Retinoids in embryonal development. Physiol Rev 2000; 80: 1021-1054.
104. Evans T. Regulation of hematopoiesis by retinoid signaling. Exp Hematol 2005; 33: 1055-1061.
105. Ward SJ, Morriss-Kay GM. The functional basis of tissue-specific retinoic acid signalling in embryos. Semin Cell Develop Biol 1997; 8: 429-435.
106. Purton LE, Bernstein ID, Collins SJ. All-trans retinoic acid delays the differentiation of primitive hematopoietic precursors (lin-c-kit+Sca-1(+)) while enhancing the terminal maturation of committed granulocyte/monocyte progenitors. Blood 1999; 94: 483-495.
107. Purton LE, Bernstein ID, Collins SJ. All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells. Blood 2000; 95: 470-477.
108. Herault O, Domenech J, Georget MT, Clement N, Colombat P, Binet C. All-trans retinoic acid prevents apoptosis of human marrow CD34+ cells deprived of hamatopoietic growth factors. Br J Haematol 2002; 118: 289-295.
109. Wolf NS. The haemopoietic microenviromnent. Clin Haematol 1979; 8: 469-500.
110. Moore KA. Recent advances in defining the hematopoietic stem cell niche. Curr Opin Hematol 2004; 11: 107-111.
111. Krzemien J, Dubois L, Makki R, Meister M, Vincent A, Crozatier M. Control of blood cell homeostasis in Drosophila larvae by the posterior signalling centre. Nature 2007; 446: 325-328.
112. Nilsson SK, Simmons PJ. Transplantable stem cells: home to specific niches. Curr Opin Hematol 2004; 11: 102-106
113. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-846.
114. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-841.
115. Gekas C, Dieterlen-Lievre F, Orkin SH, Mikkola HK. The placenta is a niche for hematopoietic stem cells. Develop Cell 2005; 8: 365-375.
116. Moore KA, Lemischka IR. Stem cell and their niches. Science 2006; 311: 1880-1885.
117. Moore KA, Ema H, Lemischka IR. In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood 1997; 89: 4337-4347.
118. Brandt JE, Galy AH, Luens KM, et al. Bone marrow repopulation by human marrow stem cells after long-term expansion culture on a porcine endothelial cell line. Exp Hematol 1998; 26: 950-961.
119. Thalmeier K, Meissner P, Reisbach G, Falk M, Brechtel A, Dormer P. Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity. Blood 1994; 83: 1799-1807.
120. Kusadasi N, Oostendorp RA, Koevoet WJ, Dzierzak EA, Ploemacher RE. Stromal cells from murine embryonic aorta-gonad-mesonephros region, liver and gut mesentery expand human umbilical cord blood-derived CAFC(week6) in extended long-term cultures. Leukemia 2002; 16: 1782-1790.
121. Johnson GR, Moore MA, Role of stem cell migration in initiation, of mouse foetal liver haemopoiesis. Nature 1975; 258: 726-728.
122. Ema H, Nakauchi H. Expansion of hematopoietic stem cells in the developing liver of a mouse embryo. Blood 2000; 95: 2284-2288.
123. Lewis ID, Almeida-Porada G, Du J, et al. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneric hosts are preserved after ex vivo culture in a noncontact system. Blood 2001; 97: 3441-3449.
124. Hackney JA, Charbord P, Brunk BP, Stoeckert CJ, Lemischka IR, Moore KA. A molecular profile of a hematopoietic stem cell niche. Proc Natl Acad Sci USA 2002; 99: 13061-13066.
125. Moore KA, Pytowski B, Witte L, Hicklin D, Lemischka IR. Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc Natl Acad Sci USA 1997; 94: 4011-4016.
126. Vodyanik MA, Bork JA, Thomson JA, Slukvin, II. Human embryonic stem cell-derived CD34+ cells: efficient production in the culture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005; 105: 617-626.
127. Ueno H, Sakita-Ishikawa M, Morikawa Y, Nakano T, Kitamura T, Saito M. A stromal cell-derived membrane protein that supports hematopoietic stem cells. Nat Immunol 2003; 4: 457-463.
128. Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118: 149-161.
129. Nilsson SK, Johnston HM, Whitty GA, et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005; 106: 1232-1239.
130. Stier S, Ko Y, Forkert R, et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 2005; 201: 1781-1791.
131. Hattori K, Heissig B, Wu Y, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 2002; 8: 841-849.
132. Kaminski WE, Lindahl P, Lin NL, et al. Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice. Blood 2001; 97: 1990-1998.
133. Leveen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Develop 1994; 8: 1875-1887.
134. Takahashi Y, Carpino N, Cross JC, Torres M, Parganas E, Ihle JN. SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J 2003; 22: 372-384.
135. Zhang J, Lodish HF. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors. Blood 2004; 104: 1679-1687.
136. Zhang Y, Li C, Jiang X, et al. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells. Exp Hematol 2004; 32: 657-664.
137. Amsellem S, Pflumio F, Bardinet D, et al. Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med 2003; 9: 1423-1427.
138. Park IK, Qian D, Kiel M, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423: 302 305.
139. Zhang P, Iwasaki-Arai J, Iwasaki H, et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 2004; 21: 853-863.
140. Hock H, Hamblen MJ, Rooke HM, et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 2004; 431: 1002-1007.
141. Douay L. Experimental culture conditions are critical for ex vivo expansion of hematopoietic cells. J Hematother Stem Cell Res 2001; 10: 341-346.
142. Devine SM, Lazarus HM, Emerson SG. Clinical application of hematopoietic progenitor cell expansion: current status and future prospects. Bone Marrow Transplant 2003; 31: 241-252.
143. Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 2003; 101: 5061-5067.
144. Zimmerman TM, Williams SF. Clinical applications of ex vivo cultured CD34+ cells and myeloid progenitors. Cytokines Cell Mol Ther 1998; 4: 257-264.
145. Astori G, Larghero J, Bonfini T, et al. Ex vivo expansion of umbilical cord blood CD34 cells in a closed system: a multicentric study. Vox Sang 2006; 90: 183-190.
146. Prince HM, Simmons PJ, Whitty G, et al. Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells. Br J Haematol 2004; 126: 536-545.
147. McNiece I, Jones R, Bearman SI, et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000; 96: 3001-3007.
148. Paquette RL, Dergham ST, Karpf E, et al. Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood 2000; 96: 2385-2390.
149. Reiffers J, Cailliot C, Dazey B, Attal M, Caraux J, Boiron JM. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet 1999; 354: 1092-1093.
150. Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002; 8: 368-376.
151. Chao NJ, Emerson SG, Weinberg KI. Stem cell transplantation (cord blood transplants). Hematology (Am Soc Hematol Educ Program) 2004: 354-371.
152. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997; 90: 4665-4678.
153. Moore MA, Hoskins I. Ex vivo expansion of cord blood-derived stem cells and progenitors. Blood Cells 1994; 20: 468-479; discussion 479-481.
154. Haylock DN, Nilsson SK. Stem cell regulation by the hematopoietic stem cell niche. Cell cycle (Georgetown, Tex 2005; 4: 1353-1355.